Literature DB >> 7003034

Correlations between methods for measurement of synergy.

M C Berenbaum.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7003034     DOI： 10.1093/infdis/142.3.476

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  16 in total

1.  Synergistic antimicrobial activity of metabolites produced by a nonobligate bacterial predator.

Authors:  Cody C Cain; Dongho Lee; Robert H Waldo; Alexis T Henry; Earl J Casida; Mansukh C Wani; Monroe E Wall; Nicholas H Oberlies; Joseph O Falkinham
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

2.  Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.

Authors:  R L White; D S Burgess; M Manduru; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus.

Authors:  Joseph Meletiadis; Spyros Pournaras; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

4.  Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo.

Authors:  J W Mouton; M L van Ogtrop; D Andes; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Effects of single and multiple flavonoids on BCRP-mediated accumulation, cytotoxicity and transport of mitoxantrone in vitro.

Authors:  Guohua An; Marilyn E Morris
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

6.  The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions.

Authors:  R C Li; J J Schentag; D E Nix
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

7.  TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth.

Authors:  David J Dowling; Simon D van Haren; Annette Scheid; Ilana Bergelson; Dhohyung Kim; Christy J Mancuso; Willemina Foppen; Al Ozonoff; Lynn Fresh; Terese B Theriot; Andrew A Lackner; Raina N Fichorova; Dmitri Smirnov; John P Vasilakos; Joe M Beaurline; Mark A Tomai; Cecily C Midkiff; Xavier Alvarez; James L Blanchard; Margaret H Gilbert; Pyone Pyone Aye; Ofer Levy
Journal:  JCI Insight       Date:  2017-03-23

8.  In vitro synergism of rifampin-cephalosporin combinations against Haemophilus influenzae type b.

Authors:  R C Gordon; R Wofford-McQueen; K Shu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

Review 9.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis.

Authors:  S C Aronoff; J D Klinger
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.